Cabotegravir used for the treatment of
[A] COVID
[B] SARS
[C] HIV
[D] CMV Infection
Cabotegravir
- Used for the treatment of HIV/AIDS
- Mechanism of Action -integrase inhibitor -Cabotegravir is an integrase strand transfer inhibitor. It blocks the HIV’s enzyme integrase, thereby preventing its genome from being integrated into the human cells’ DNA.
- As this is a necessary step for the virus to replicate, its further spread is hampered.
- In December 2021, the U.S. Food and Drug Administration approved cabotegravir for pre-exposure prophylaxis (PrEP) in at-risk people
